Under MRA, Japan is to recognise Indian medical degrees and treat the country's doctors and other medical personnel on par with its own.
Abu Dhabi-based serial entrepreneur BR Shetty walks us through his life and career and shares the imminent lessons he's learned.
Bharatiya Janata Party member of Parliament and former investment manager Jayant Sinha on Friday said the country has potential to become a $5 trillion economy.
Sheela Bhatt, who is travelling with Prime Minister Manmohan Singh on his two-nation visit, analyses the outcome of crucial talks between the PM and his Chinese counterpart in Beijing.
The country had the third-largest number of people living with disease.
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
'India easily remains one among the more attractive large economies, with high growth and stable/improving macros, as a top investment destination.' 'We are looking pretty good.'
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Few top honchos of India Inc did very well in 2014.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances